Engagement of platelet membrane glycoprotein (GP) Ib-IX-V by von Willebrand factor triggers Ca++-dependent activation of αIIbβ3, resulting in (patho)physiological thrombus formation. It is demonstrated here that the cytoplasmic domain of GPIb-IX-V associates with cytosolic calmodulin. First, an anti-GPIbα antibody coimmunoprecipitated GPIb-IX and calmodulin from platelet lysates. Following platelet stimulation, calmodulin dissociated from GPIb-IX and, like the GPIb-IX–associated proteins 14-3-3ζ and p85, redistributed to the activated cytoskeleton. Second, a synthetic peptide based on the cytoplasmic sequence of GPIbβ, R149–L167 (single-letter amino acid codes), affinity-isolated calmodulin from platelet cytosol in the presence of Ca++ as confirmed by comigration with bovine calmodulin on sodium dodecyl sulfate–polyacrylamide gels, by sequence analysis, and by immunoreactivity with the use of an anticalmodulin antibody. The membrane-proximal GPIbβ sequence was analogous to a previously reported calmodulin-binding sequence in the leukocyte adhesion receptor, L-selectin. In addition, the cytoplasmic sequence of GPV, K529–G544, was analogous to a calmodulin-binding IQ motif within the α1c subunit of L-type Ca++ channels. Calmodulin coimmunoprecipitated with GPV from resting platelet lysates, but was dissociated in stimulated platelets. A GPV-related synthetic peptide also bound calmodulin and induced a Ca++-dependent shift on nondenaturing gels. Together, these results suggest separate regions of GPIb-IX-V can directly bind calmodulin, and this novel interaction potentially regulates aspects of GPIb-IX-V–dependent platelet activation.

The platelet membrane glycoprotein (GP) Ib-IX-V complex binds to the adhesive ligand von Willebrand factor (vWF), an interaction that initiates platelet adhesion and aggregation at high-shear stress.1-4 Adhered platelets become activated, with elevation of cytosolic Ca++ and triggering of signaling pathways, leading to cytoskeletal rearrangements and activation of αIIbβ3 integrin (GPIIb-IIIa), which binds to fibrinogen or vWF, resulting in platelet aggregation.5-7The pathway by which ligand binding to GPIb-IX-V leads to αIIbβ3 activation and thrombus formation is poorly understood, although delineation of early signaling events mediated by GPIb-IX-V offers potential targets for therapeutic intervention.

The GPIb-IX-V complex consists of 4 membrane-spanning glycoproteins. GPIbα is disulfide-linked to GPIbβ, forming GPIb, which is noncovalently associated with GPIX in a 1:1 complex. GPIb-IX-V is composed of GPIb-IX and GPV in a 2:1 ratio.3 In extracts of platelets in the presence of Triton X-100 detergent, GPIb-IX remains a complex, while GPV is dissociated.8,9 The extracellular, N-terminal 282 residues of GPIbα contain the vWF binding site.3 10 

Recent studies have identified signaling molecules associated with the cytoplasmic domain of GPIb-IX-V that appear to be important for the function of the receptor. One of these molecules is 14-3-3ζ, which directly binds to one or more sequences within the cytoplasmic domain of GPIb-IX-V.11-15 This interaction was implicated in the pathway leading from engagement of GPIb-IX-V to activation of αIIbβ3 in a model system that involved expression of both receptors in Chinese hamster ovary cells.5 Further studies have shown coassociation of the GPIb-IX–14-3-3 complex with the p85 subunit of phosphatidylinositol 3-kinase (PI 3-kinase).16The rapid translocation of these signaling proteins to the cytoskeleton following platelet activation indicated a potential role in formation of 3-position phosphoinositide-signaling molecules in this subcellular compartment.

In this study, we demonstrate that like 14-3-3ζ and p85, calmodulin is redistributed to the activated cytoskeleton following platelet stimulation. In addition, we show the novel association of calmodulin with GPIb-IX and GPV. We further demonstrate that synthetic peptides based on discrete cytoplasmic sequences of GPIbβ (R149–L167 [single-letter amino acid codes]) and GPV (K529–G544 [single-letter amino acid codes]) support calmodulin binding through conserved calmodulin-recognition motifs. The interaction of the GPIb-IX-V complex with cytosolic calmodulin may be an important component in regulating GPIb-IX-V–dependent adhesion, actin polymerization, and/or signaling.

Bovine serum albumin (BSA), bovine calmodulin, prostaglandin E1 (PGE1), phenylmethylsulfonyl fluoride (PMSF), and leupeptin were purchased from Sigma (St Louis, MO).N-ethylmaleimide (NEM) was purchased from Calbiochem (San Diego, CA). Synthetic peptides based on cytoplasmic sequences of GPIbβ17 or GPV,18 in some cases containing an N-terminal cysteine to facilitate coupling, were purified by reverse-phase high-pressure liquid chromatography (HPLC) and characterized by mass spectroscopy (Chiron Mimotopes) (Clayton, Victoria, Australia). A control peptide, CLKKLIRSPSIPHQY (single-letter amino acid codes), was obtained from the same supplier.

Antibodies

Rabbit polyclonal immunoglobulin G (IgG) against the soluble extracellular portion of GPIbα (glycocalicin) was raised and purified as previously described.8 19 A rabbit polyclonal antibody against human GPV was the kind gift of Dr David Phillips (COR Therapeutics, San Francisco, CA). Rabbit polyclonal IgG against human actin-binding protein was provided by Dr Dominic Chung (University of Washington, Seattle). Rabbit polyclonal antisera against the p85 subunit of PI 3-kinase and mouse monoclonal anticalmodulin IgG were obtained from Upstate Biotechnology (Lake Placid, NY).

Preparation of washed platelets and platelet subcellular fractions

Platelets were obtained from healthy volunteers and washed by means of a previously described method.19,20 Washed platelets (5 × 108/mL) were either left unstimulated or stimulated with 1 U/mL thrombin for 5 minutes at room temperature. Following thrombin activation, platelets were lysed with 1 vol Triton X-100 lysis buffer (200 mM Tris-HCl, pH 7.4, 10% Triton X-100, 50 mM ethyleneglycotetraacetic acid [EGTA], 4 mM leupeptin, 4 mM aprotinin, 2.5 mg/mL PMSF) to 9 vol platelets and rocked at 4°C for 1 hour. Under these conditions, GPV dissociates from GPIb-IX.8,9Lysates were centrifuged at 15 400g for 10 minutes to separate the Triton X-100 soluble and insoluble (actin cytoskeletal) extracts, and the platelet subcellular fractions were isolated as previously described.19 20 The cytoskeletal pellet was solubilized by incubation with 2 × radioimmunoprecipitation-assay buffer (20 mM NaH2PO4, pH 7.0, 0.15 M NaCl, 2 mM EDTA, 2 mM PMSF, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]) for 1 hour at 4°C, followed by centrifugation at 15 400g for 10 minutes.

Immunoprecipitation of platelet lysates

Immunoprecipitation from lysates with rabbit nonimmune IgG, anti-GPIbα (glycocalicin) IgG, or anti-GPV IgG was carried out as previously described.13,19 For some experiments, platelets were pretreated with a final concentration of either 3 nM PGE1 or 1 mM NEM prior to lysis and immunoprecipitation. For Western blotting, samples were electrophoresed on SDS–polyacrylamide gels under reducing conditions, electrotransferred to nitrocellulose, blocked with 5% skim milk powder in TS buffer (0.02 M Tris-HCl, 0.15 M NaCl, pH 7.4), and immunoblotted with anti-GPIbα, anti-p85, anti–actin-binding protein, or anticalmodulin antibodies, also as described elsewhere.13 19 Blots were visualized by means of the appropriate horseradish peroxidase–coupled antirabbit or antimouse second antibody (Silenus, Hawthorn, Australia), and the electrogenerated chemiluminescence (ECL) detection system (Amersham, Buckinghamshire, United Kingdom).

Preparation of peptide-affinity resins

Synthetic peptides corresponding to the GPIbβ sequence, R149–L167, the GPV sequence, K529–G544, or the control peptide CLKKLIRSPSIPHQY were coupled to BSA (0.25 mg peptide per 10 mg BSA) with m-maleimidobenzoyl-N-hydroxysuccinimide (Pierce, Rockford, IL) as previously described.13 The peptide-BSA conjugate or peptide alone was coupled to a 1:1 mixture of Affi-gel 10 and 15 (0.25 mg peptide per 5 mL resin, and 10 mg peptide-BSA per 5 mL resin, respectively) according to the manufacturer's instructions (Bio-Rad, Richmond, CA). Resins coupled to peptide and peptide-BSA were pooled and washed with TS buffer.

Peptide-affinity chromatography of platelet cytosol

Cytosol from 10 U day-old washed human platelets was prepared as previously described.8 The cytosol was dialyzed into TS buffer, CaCl2 added to give a final concentration of 1 mM, and loaded at 25 mL/h onto 10 × 1 cm GPIbβ-peptide, GPV-peptide, or control-peptide columns and washed with TS buffer containing 1 mM CaCl2. Bound protein was eluted by 10 mM EGTA in TS buffer, and fractions (2 mL) were analyzed on SDS–5%-to-20% polyacrylamide gels under reducing conditions as described elsewhere.13 

Nondenaturing gel shift assay

The effect that a synthetic peptide based on the GPV sequence, K529–G544, had on the migration of bovine calmodulin was analyzed on nondenaturing gels as previously described.21-23Calmodulin (approximately 0.3 nmol) was mixed with 0 to 3.0 nmol GPV-related peptide or a control peptide (CLKKLIRSPSIPHQY) in 0.1 M Tris-HCl, pH 7.5, containing 4 M urea in the presence of either 1 mM Ca++ or 10 mM EGTA. After incubating for 30 minutes at 22°C, 0.5 vol 50% glycerol was added; samples were electrophoresed on 12.5% polyacrylamide gels containing 4 M urea at 50 mA for 3 hours; and gels were stained with Coomassie blue.

Amino acid sequence analysis

For sequence analysis, protein was dialyzed into distilled water and digested with trypsin (0.1 mg trypsin per milligram protein) overnight at 37°C. Tryptic fragments were separated by reverse-phase HPLC eluted by a linear 0% to 60% (vol/vol) acetonitrile gradient and sequenced as previously described.24 

Coprecipitation of calmodulin with GPIb-IX or GPV from platelet lysates

Prior to investigating whether the GPIb-IX-V complex bound calmodulin, platelet lysates were first immunoblotted with an anticalmodulin antibody. As shown in Figure1, calmodulin was present in the cytosolic fraction of both untreated and thrombin-stimulated platelets. Interestingly, activation of platelets by thrombin resulted in a redistribution of cytosolic calmodulin and markedly increased association with the actin cytoskeleton (Figure 1). For comparison, Figure 1 also shows the same samples immunoblotted with an antibody against the p85 subunit of PI 3-kinase, a protein previously demonstrated as becoming associated with the cytoskeleton following platelet activation.16 From the relative intensity of the blots and the protein loaded per lane (4.5-fold more in the nonstimulated cytosol compared with the stimulated cytoskeletal fraction), it may be estimated that up to 25% of total calmodulin could be translocated to the cytoskeleton following stimulation.

Fig. 1.

Translocation of platelet proteins to the activated cytoskeleton.

Platelets that were untreated or stimulated with α-thrombin (1 U/mL, final concentration) for 5 minutes at room temperature were lysed, and cytosolic and actin cytoskeletal (CYSK) fractions were isolated and immunoblotted with antibodies to p85, calmodulin, GPIbα, or GPV. Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are typical of 3 separate experiments.

Fig. 1.

Translocation of platelet proteins to the activated cytoskeleton.

Platelets that were untreated or stimulated with α-thrombin (1 U/mL, final concentration) for 5 minutes at room temperature were lysed, and cytosolic and actin cytoskeletal (CYSK) fractions were isolated and immunoblotted with antibodies to p85, calmodulin, GPIbα, or GPV. Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are typical of 3 separate experiments.

Close modal

When platelets were extracted with Triton X-100, a condition in which GPV is dissociated from GPIb-IX,8,9 immunoprecipitation of GPIb-IX by an anti-GPIbα polyclonal IgG showed a specific coimmunoprecipitation of a 22-kd band as detected by Western blot analysis with an anticalmodulin antibody (Figure2A). Calmodulin was also coimmunoprecipitated by anti-GPV polyclonal IgG (Figure 2B). These experiments were carried out in the presence of EGTA, suggesting that the association of calmodulin with GPIb-IX or GPV could occur even in the absence of Ca++. Calmodulin specifically coimmunoprecipitated with GPIb-IX or GPV from the Triton X-100 soluble fraction of unstimulated platelets, but was drastically diminished in thrombin-stimulated platelets, suggesting that complexes of GPIb-IX or GPV and calmodulin were dissociated in activated platelets (Figure 2). Under these conditions, the amount of GPIb-IX or GPV in the platelet cytosol is essentially unchanged (Figure 1).16Interestingly, no association between calmodulin and either GPIb-IX or GPV was observed in the cytoskeletal fraction, suggesting that calmodulin's association with the actin cytoskeleton in activated platelets was independent of GPIb-IX or GPV (Figure 2, cf Figure 1) or that it dissociated from GPIb-IX and GPV owing to the treatment with cytoskeletal extraction buffer. Although we cannot exclude the latter possibility, both 14-3-3ζ and the p85 subunit of PI 3-kinase remain associated with GPIb-IX under these extraction conditions.16 Calmodulin was not immunoprecipitated from either fraction by nonimmune IgG (Figure 2). Together, these results are consistent with colocalization of calmodulin and GPIb-IX-V in resting platelets, rather than coprecipitation due to indirect association mediated by the cytoskeleton.

Fig. 2.

Coassociation of calmodulin and GPIb-IX-V in platelets.

Triton X-100 soluble and actin cytoskeletal (CYSK) fractions isolated from platelets either unstimulated or stimulated with thrombin for 5 minutes were immunoprecipitated (IP) by means of GPIb antibodies (A) or GPV antibodies (B) compared with nonimmune sera (NonI), and immunoblotted by means of antibodies to calmodulin. Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are typical of 3 separate experiments.

Fig. 2.

Coassociation of calmodulin and GPIb-IX-V in platelets.

Triton X-100 soluble and actin cytoskeletal (CYSK) fractions isolated from platelets either unstimulated or stimulated with thrombin for 5 minutes were immunoprecipitated (IP) by means of GPIb antibodies (A) or GPV antibodies (B) compared with nonimmune sera (NonI), and immunoblotted by means of antibodies to calmodulin. Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are typical of 3 separate experiments.

Close modal

It has previously been shown that phosphorylation of GPIbβ at S166 enhances binding of 14-3-3ζ.13,15 Treatment of platelets with PGE1 results in protein kinase A (PKA)–dependent phosphorylation of platelet GPIbβ and enhanced 14-3-3ζ binding.15 25 We therefore assessed whether PGE1 treatment of platelets affected association of calmodulin. As shown in Figure 3A, the extent of calmodulin that coimmunoprecipitated with GPIb-IX from the Triton X-100 soluble fraction of platelet lysates was not significantly affected by PGE1 treatment, suggesting calmodulin association was not competing with 14-3-3ζ binding to GPIbβ.

Fig. 3.

Effect of PGE1 and NEM treatment on calmodulin association with GPIb-IX.

(A) Triton X-100 soluble fraction of platelets either untreated or treated with 3 nM PGE1 for 5 minutes at room temperature were immunoprecipitated by means of nonimmune sera (NonI) or GPIb antibodies and were immunoblotted by means of antibodies to calmodulin. (B) Triton X-100 soluble fractions of platelets either untreated or treated with 1 mM NEM for 5 minutes at room temperature were immunoprecipitated by means of nonimmune sera (NonI) or GPIb antibodies and were immunoblotted by means of antibodies to actin-binding protein (ABP, upper panel) or calmodulin (lower panel). Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are representative of 3 separate experiments.

Fig. 3.

Effect of PGE1 and NEM treatment on calmodulin association with GPIb-IX.

(A) Triton X-100 soluble fraction of platelets either untreated or treated with 3 nM PGE1 for 5 minutes at room temperature were immunoprecipitated by means of nonimmune sera (NonI) or GPIb antibodies and were immunoblotted by means of antibodies to calmodulin. (B) Triton X-100 soluble fractions of platelets either untreated or treated with 1 mM NEM for 5 minutes at room temperature were immunoprecipitated by means of nonimmune sera (NonI) or GPIb antibodies and were immunoblotted by means of antibodies to actin-binding protein (ABP, upper panel) or calmodulin (lower panel). Blots were visualized by means of a peroxidase-coupled second antibody and the ECL reagent. Results are representative of 3 separate experiments.

Close modal

It has also previously been shown that treatment of platelets with NEM causes dissociation of actin-binding protein from GPIbα.8 This is demonstrated by immunoblotting of anti-GPIb immunoprecipates with an anti–actin-binding protein antibody in Figure 3B. Treatment of platelets with NEM also resulted in a reduction in the level of calmodulin associated with GPIb-IX (Figure3B). The level of calmodulin associated with GPIb-IX in NEM-treated compared with untreated platelets, however, was reduced by 40% to 50% in 3 separate experiments. These data suggest that calmodulin association with the GPIb-IX complex is not dependent on coassociation of actin-binding protein but may be stabilized in part by its coassociation.

Binding of calmodulin to a synthetic peptide based on the cytoplasmic sequence of GPIbβ

To investigate potential calmodulin binding sites within GPIb-IX-V, we observed that a sequence within the cytoplasmic tail of GPIbβ (R149–L167) was analogous to calmodulin-binding motifs found in other proteins (Figure 4). A synthetic peptide corresponding to the GPIbβ sequence, R149–L167 (B1 peptide), was coupled to agarose. Platelet cytosol (Figure5A) was loaded onto the affinity resin in the presence of 1 mM Ca++, and bound protein was eluted by 10 mM EGTA. While no detectable proteins eluted from a control peptide (CLKKLIRSPSIPHQY) column (Figure 5B), a protein eluted from the B1 peptide column was approximately 22 kd on SDS–polyacrylamide gel electrophoresis under both reducing (Figure 5C) and nonreducing (not shown) conditions. Two lines of evidence suggested that the protein eluted from the B1 column was calmodulin. First, it comigrated with bovine calmodulin on SDS–polyacrylamide gels and was immunoblotted by an anticalmodulin antibody (Figure 5D). Second, the amino acid sequence of a tryptic fragment of the purified protein revealed a sequence (R/K)XVMXNLGE that was conserved in human calmodulin (RHVMTNLGE).29 

Fig. 4.

Sequences within GPIbβ compared with other calmodulin-recognition sequences.

(A) Sequence alignment of a cytoplasmic sequence of GPIbβ, R149–L167,17 with calmodulin-binding sequences in a model calmodulin-binding control peptide CBCP,23,26L-selectin,27 and m7A.28 Identical amino acids or conserved substitutions are boxed. (B) Helical wheel representation of the GPIbβ sequence (R149–L167) compared with the amphipathic α-helical peptide CBCP.

Fig. 4.

Sequences within GPIbβ compared with other calmodulin-recognition sequences.

(A) Sequence alignment of a cytoplasmic sequence of GPIbβ, R149–L167,17 with calmodulin-binding sequences in a model calmodulin-binding control peptide CBCP,23,26L-selectin,27 and m7A.28 Identical amino acids or conserved substitutions are boxed. (B) Helical wheel representation of the GPIbβ sequence (R149–L167) compared with the amphipathic α-helical peptide CBCP.

Close modal
Fig. 5.

Affinity chromatography of whole-platelet lysates.

(A) SDS–5%-to-20% polyacrylamide gel of platelet lysate electrophoresed under reducing conditions and stained with Coomassie blue. (B-C) Protein from platelet lysate (A) that had bound to a control peptide column (B) or a GPIbβ (R149–L167) peptide-agarose column (B1 peptide) (C) was eluted with 10 mM EGTA in the washing buffer. Eluted 2-mL fractions1-4 were analyzed on SDS–5%-to-20% polyacrylamide gels under reducing conditions and stained with Coomassie blue. (D) Immunoblot with anticalmodulin monoclonal antibody of purified bovine calmodulin (CaM), the 22-kd protein isolated from platelet cytosol by EGTA elution from the GPIbβ peptide column (B1) or a GPV (K529–G544) peptide-agarose column (V). The proteins were electrophoresed on SDS–5%-to-20% polyacrylamide gels, electrotransferred to nitrocellulose, and visualized by means of a peroxidase-conjugated anti–mouse IgG and the ECL reagent.

Fig. 5.

Affinity chromatography of whole-platelet lysates.

(A) SDS–5%-to-20% polyacrylamide gel of platelet lysate electrophoresed under reducing conditions and stained with Coomassie blue. (B-C) Protein from platelet lysate (A) that had bound to a control peptide column (B) or a GPIbβ (R149–L167) peptide-agarose column (B1 peptide) (C) was eluted with 10 mM EGTA in the washing buffer. Eluted 2-mL fractions1-4 were analyzed on SDS–5%-to-20% polyacrylamide gels under reducing conditions and stained with Coomassie blue. (D) Immunoblot with anticalmodulin monoclonal antibody of purified bovine calmodulin (CaM), the 22-kd protein isolated from platelet cytosol by EGTA elution from the GPIbβ peptide column (B1) or a GPV (K529–G544) peptide-agarose column (V). The proteins were electrophoresed on SDS–5%-to-20% polyacrylamide gels, electrotransferred to nitrocellulose, and visualized by means of a peroxidase-conjugated anti–mouse IgG and the ECL reagent.

Close modal

Interaction of calmodulin with the cytoplasmic tail of GPV

The cytoplasmic tail of GPV also contained a sequence with similarity to an IQ motif (Figure 6) previously reported to interact with calmodulin in a Ca++-dependent manner.21 As described above for the GPIbβ peptide, an affinity column of the GPV peptide coupled to agarose specifically bound a 22-kd protein from platelet cytosol in the presence of Ca++. The bound protein was eluted by EGTA, comigrated with bovine calmodulin on SDS–polyacrylamide gels, and was immunoblotted by an anticalmodulin antibody (Figure 5D). To further examine whether this sequence in GPV bound calmodulin, we also used a nondenaturing gel shift assay previously shown to specifically identify calmodulin-binding peptides.21-23 A synthetic peptide corresponding to the entire GPV cytoplasmic sequence, K529–G544, induced a concentration-dependent shift in calmodulin migration in the presence of Ca++, but not in the presence of EGTA (Figure7). In contrast to the GPV-related peptide, a positively charged control peptide, CLKKLIRSPSIPHQY, did not affect calmodulin migration in the gel shift assay when tested at concentrations up to a 10-fold molar excess over calmodulin (data not shown). Related gel shift experiments with the B1 peptide were not technically feasible owing to poor solubility of this peptide at high concentrations.

Fig. 6.

Sequence comparison of the GPV cytoplasmic tail and the IQ motif.

(A) Alignment of the cytoplasmic sequence of GPV, K529–G544,18 with the conserved IQ motif of the L-type ion channel subunit α1c,21RC3/neurogranin,30,31 and GAP-43.32,33 The solid lines above the α1c sequence indicate residues that form the IQ motif. The lower line indicates residues minimally required for calmodulin binding by RC3 (solid line), while additional upstream residues involved in the Ca++-sensitive interaction include those indicated by the dashed line.32 (B) Helical wheel representation of the GPV sequence (K529–G544) compared with the sequence of α1c.

Fig. 6.

Sequence comparison of the GPV cytoplasmic tail and the IQ motif.

(A) Alignment of the cytoplasmic sequence of GPV, K529–G544,18 with the conserved IQ motif of the L-type ion channel subunit α1c,21RC3/neurogranin,30,31 and GAP-43.32,33 The solid lines above the α1c sequence indicate residues that form the IQ motif. The lower line indicates residues minimally required for calmodulin binding by RC3 (solid line), while additional upstream residues involved in the Ca++-sensitive interaction include those indicated by the dashed line.32 (B) Helical wheel representation of the GPV sequence (K529–G544) compared with the sequence of α1c.

Close modal
Fig. 7.

Interaction of the GPV cytoplasmic peptide and calmodulin.

Nondenaturing gel shift of calmodulin (0.3 nmol) in the presence of increasing concentrations of the GPV synthetic peptide, based on K529–G544. Upper and lower panels are in the presence of 1 mM Ca++ or 10 mM EGTA, respectively. Gels were stained with Coomassie blue.

Fig. 7.

Interaction of the GPV cytoplasmic peptide and calmodulin.

Nondenaturing gel shift of calmodulin (0.3 nmol) in the presence of increasing concentrations of the GPV synthetic peptide, based on K529–G544. Upper and lower panels are in the presence of 1 mM Ca++ or 10 mM EGTA, respectively. Gels were stained with Coomassie blue.

Close modal

The platelet membrane GPIb-IX-V complex binds to the adhesive ligand vWF and initiates platelet adhesion and aggregation at high-shear stress in flowing blood.1-4 Elevation of cytosolic Ca++ in activated platelets leads to actin polymerization and to cytoskeletal rearrangement and activation of αIIbβ3, resulting in platelet aggregation and contraction.5,6 Recent studies have suggested that 14-3-3ζ, which directly binds to one or more sequences within the cytoplasmic domain of GPIb-IX-V,11-13 may be involved in linking engagement of GPIb-IX-V with activation of αIIbβ3.5 The p85 subunit of PI 3-kinase has also been identified as being associated with GPIb-IX-V in platelets.16 

In the current study, we have found an additional association between the cytoplasmic domain of GPIb-IX-V and the cytosolic regulatory protein calmodulin. Immunoblotting with anticalmodulin antibody showed that calmodulin was present in the soluble fraction of both resting and thrombin-activated platelets, but as with 14-3-3ζ and p85,16 there was an increased association with the cytoskeleton following activation. Calmodulin coimmunoprecipitated with GPIb-IX or GPV from the Triton X-100 soluble fraction of resting platelets, but not thrombin-stimulated platelets, suggesting the GPIb-IX-V–calmodulin complex dissociates in activated platelets.

Within the cytoplasmic domain of GPIbβ, a membrane-proximal 16-residue sequence was similar to other reported calmodulin-binding sequences (Figure 4). In Figure 4B, the GPIbβ sequence is compared with CBCP,23 a nonphysiological calmodulin-binding control peptide that is representative of a positively charged, amphipathic α-helix typical of calmodulin-recognition sites in other proteins.23,26,33,34 In addition, a sequence comprising the 16-residue cytoplasmic tail of GPV resembled the IQ motif described in the α1c subunit of the L-type Ca++ channel (Figure 6). Calmodulin is a critical Ca++ sensor for both inactivation and facilitation of L-type Ca++ channels, and mutation of I1624 within this motif dramatically affects the Ca++-dependent feedback regulation of this channel.21 Conserved motifs of the type represented in either GPIbβ (Figure 4) or GPV (Figure 6) have been reported to specifically bind calmodulin in a range of different proteins.21-23,26-34 Both motifs are net positively charged, but whether they recognize identical or overlapping sites on calmodulin has not been determined. The GPIbβ- and GPV-related peptides both affinity-isolated calmodulin from platelet cytosol in the presence of Ca++. In contrast to calmodulin's association with intact GPIb-IX or GPV in platelet extracts that contained EGTA, binding of calmodulin to synthetic peptides based on GPIbβ or GPV was observed only in the presence of Ca++. This suggests the Ca++ dependency and/or affinity of the interaction with calmodulin is different in the intact receptor. This is not inconsistent with other reports of calmodulin-binding peptides from RC3 (neurogranin). In this case, Ca++ sensitivity of interactions with calmodulin was conferred by specific residues immediately upstream of the calmodulin-binding site31(Figure 6A). The GPV peptide also induced a shift in migration of bovine calmodulin on nondenaturing gels in the presence of Ca++. Maximal shift was observed at a 10-fold molar excess of peptide to calmodulin, suggesting the interaction was of lower affinity than that reported for the α1c-related peptide, which required equimolar peptide for maximal shift (dissociation constant [KD], approximately 30 nM),21 but is of higher affinity than a peptide based on the α1a subunit of the P/Q ion channel where greater than 50-fold excess of peptide was required (KD, approximately 2 μM).22 

Structure-function analysis has revealed several striking similarities between platelet GPIbβ and the neural cell–specific, cytoskeletal regulatory protein GAP-43 (Figure 8A). Both GPIbβ (as part of GPIb-IX) and GAP-43 bind calmodulin independently of Ca++ (this study and Baudier et al32), are palmitylated at a site N-terminal to the calmodulin recognition sequence34,38 and are serine-phosphorylated within or proximal to the calmodulin-binding site by PKA or protein kinase C (PKC), respectively.25,35,39,40Interestingly, phosphorylation of GPIbβ by PKA inhibits the actin polymerization that normally occurs following platelet activation.25 In contrast, GAP-43 becomes concentrated at the cytoplasmic face of the membrane in growth cones during axon development and stabilizes long actin filaments when phosphorylated by PKC.40 Unphosphorylated GAP-43 reduces actin filament length, and calmodulin association potentiates this effect. It is postulated that association of calmodulin with GAP-43, myristylated alanine-rich C kinase substrates (MARCKS), and other proteins modulates their PKC-dependent phosphorylation.31,33,34,40 It has also been shown that the MARCKS-related calmodulin-binding peptide directly facilitates actin polymerization and bundle formation.41 In addition, GAP-43, MARCKS, and CAP23 have been shown to colocalize with PI(4,5)P2 and regulate actin polymerization at plasmalemmal rafts in neural cell lines.42 This process also involves colocalized PI 3-kinase,43 a signaling protein also specifically associated with GPIb-IX-V.16 

Fig. 8.

Map of the calmodulin-binding subunits of the GPIb-IX-V complex.

(A) Cytoplasmic domain of GPIbβ17 showing sequences that interact with calmodulin (this study), and the RXSXTXP motif that interacts with 14-3-3ζ.13 The asterisk indicates the phosphorylation site at S166.35 The structure of GPIbβ is compared with that of GAP-43.31,32 (B) Schematic representation of GPIb-IX-V showing locations of sequences that bind calmodulin (this study), 14-3-3ζ,12-14 and actin-binding protein.36 37 

Fig. 8.

Map of the calmodulin-binding subunits of the GPIb-IX-V complex.

(A) Cytoplasmic domain of GPIbβ17 showing sequences that interact with calmodulin (this study), and the RXSXTXP motif that interacts with 14-3-3ζ.13 The asterisk indicates the phosphorylation site at S166.35 The structure of GPIbβ is compared with that of GAP-43.31,32 (B) Schematic representation of GPIb-IX-V showing locations of sequences that bind calmodulin (this study), 14-3-3ζ,12-14 and actin-binding protein.36 37 

Close modal

In a manner similar to calmodulin's effect on PKC phosphorylation of GAP-43, calmodulin could regulate PKA access to GPIbβ and thereby influence activation-dependent actin reorganization in platelets. This possibility deserves future investigation. In this regard, the calmodulin-binding sequence of GPIbβ is immediately upstream of a conserved RXSXTXP motif that binds 14-3-3ζ and includes the PKA phosphorylation site (Figure 8A) (this study, Andrews et al,13 and Calverly et al14). Phosphorylation of this sequence inhibits actin polymerization (see above) and increases the affinity of GPIbβ for 14-3-3ζ.13,15 Our data suggest that calmodulin association with GPIb-IX is not affected by phosphorylation of GPIbβ, an event previously shown to increase 14-3-3ζ association with GPIbβ.13 15 This implies both calmodulin and 14-3-3ζ can potentially bind GPIb-IX. We also showed that NEM treatment diminished the level of GPIb-IX–associated calmodulin. This suggests not only that actin-binding protein and calmodulin can independently associate with GPIb-IX, but also that the calmodulin association with GPIb-IX may be in part stabilized by the coassociation with the GPIb-IX-V complex of actin-binding protein. Further studies are needed, however, to investigate whether NEM treatment may directly decrease the interaction of calmodulin with GPIb-IX independently of actin-binding protein association.

Like 14-3-3ζ, calmodulin binds a wide range of ligands, including calmodulin-dependent kinases I and II, and phosphatases such as calcineurin, in addition to cytoskeletal proteins.33,34GPIb-IX-V, with high copy number (greater than 10 000 per platelet) and multiple sites for calmodulin and 14-3-3ζ (Figure 8B), could therefore be involved in submembranous localization of both calmodulin- and 14-3-3ζ–associated signaling proteins. Dissociation of the Ca++-independent interactions of calmodulin and GPIb-IX-V (this study), and elevation of cytosolic Ca++ following platelet activation,1 may facilitate Ca++-dependent calmodulin activation of as-yet-unidentified signaling or cytoskeletal proteins.

In summary, this study has identified calmodulin as a GPIb-IX-V–associated protein in platelets, and its specific recognition sequences might ultimately provide novel targets for therapeutic regulation of platelet activation. Further studies are currently underway to define the precise functional consequences of the GPIb-IX-V–calmodulin interaction.

We thank Carmen Llerena, Andrea Aprico, and Catherine Upton for excellent technical assistance; Dr A. Ian Smith for sequence analysis; and Dr Walter G. Thomas, Dr Yang Shen, and Dr Elizabeth E. Gardiner for helpful discussions.

Supported in part by grants from the National Health and Medical Research Council of Australia, and the National Heart Foundation of Australia.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Kroll
MH
Hellums
JD
McIntyre
LV
Schafer
AI
Moake
JL
Platelets and shear stress.
Blood.
88
1996
1525
1541
2
Savage
B
Almus-Jacobs
F
Ruggeri
ZM
Synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.
Cell.
94
1998
657
666
3
Andrews
RK
Shen
Y
Gardiner
EE
Dong
J-F
López
JA
Berndt
MC
The glycoprotein Ib-IX-V complex in platelet adhesion and signaling.
Thromb Haemost.
82
1999
357
364
4
Kulkarni
S
Dopheide
SM
Yap
CL
et al
A revised model of platelet aggregation.
J Clin Invest.
105
2000
783
791
5
Gu
M
Xi
X
Englund
GD
Berndt
MC
Du
X
Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin αIIbβ3 using a reconstituted mammalian cell expression model.
J Cell Biol.
147
1999
1085
1096
6
Zaffran
Y
Meyer
SC
Negrescu
E
Reddy
KB
Fox
JEB
Signaling across the platelet adhesion receptor glycoprotein Ib-IX induces αIIbβ3 activation both in platelets and a transfected Chinese hamster ovary cell system.
J Biol Chem.
275
2000
16779
16787
7
Yap
CL
Hughan
SC
Cranmer
SL
et al
Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin αIIbβ3 studies in human platelets and transfected Chinese hamster ovary cells.
J Biol Chem.
275
2000
41377
41388
8
Berndt
MC
Gregory
C
Kabral
A
Zola
H
Fournier
D
Castaldi
PA
Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
Eur J Biochem.
151
1985
637
649
9
Modderman
PW
Admiraal
LG
Sonnenberg
A
von dem Borne
AE
Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane.
J Biol Chem.
267
1992
364
369
10
Shen
Y
Romo
GM
Dong
J-F
et al
Requirement of leucine-rich repeats of GP Ibα for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.
Blood.
95
2000
903
910
11
Du
X
Harris
SJ
Tetaz
TJ
Ginsberg
MH
Berndt
MC
Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex.
J Biol Chem.
269
1994
18287
18290
12
Du
X
Fox
JE
Pei
S
Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ibα.
J Biol Chem.
269
1996
7362
7367
13
Andrews
RK
Harris
SJ
McNally
T
Berndt
MC
Binding of purified 14-3-3 ζ signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
Biochemistry.
37
1998
638
647
14
Calverly
DC
Kavanagh
TJ
Roth
GJ
Human signaling protein 14-3-3ζ interacts with platelet glycoprotein Ib subunits Ibα and Ibβ.
Blood.
91
1998
1295
1303
15
Feng
S
Christodoulides
N
Resendiz
JC
Berndt
MC
Kroll
MH
Cytoplasmic domains of GPIbα and GPIbβ regulate 14-3-3ζ binding to GPIb/IX/V.
Blood.
95
2000
551
557
16
Munday
AD
Berndt
MC
Mitchell
CA
Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3ζ.
Blood.
96
2000
577
584
17
López
JA
Chung
DW
Fujikawa
K
Hagen
FS
Davie
EW
Roth
GJ
The α and β chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.
Proc Natl Acad Sci U S A.
85
1988
2135
2139
18
Lanza
F
Morales
M
de La Salle
C
et al
Cloning and characterization of the gene encoding the human platelet glycoprotein V: a member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation.
J Biol Chem.
268
1993
20801
20807
19
Munday
AD
Norris
FA
Caldwell
KK
Brown
S
Majerus
PW
Mitchell
CA
The inositol polyphosphate 4-phosphatase forms a complex with phosphatidylinositol 3-kinase in human platelet cytosol.
Proc Natl Acad Sci U S A.
96
1999
3640
3645
20
Jackson
SP
Schoenwaelder
SM
Yuan
Y
Rabinowitz
I
Salem
HH
Mitchell
CA
Adhesion receptor activation of phosphatidylinositol 3-kinase von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets.
J Biol Chem.
269
1994
27093
27099
21
Zühlke
RD
Pitt
GS
Deisseroth
K
Tsien
RW
Reuter
H
Calmodulin supports both inactivation and facilitation of L-type ion channels.
Nature.
399
1999
159
162
22
Lee
A
Wong
ST
Gallagher
D
et al
Ca2+/calmodulin binds to modulates P/Q-type calcium channels.
Nature.
399
1999
155
159
23
Thomas
WG
Pipolo
L
Qian
H
Identification of a Ca2+/calmodulin-binding domain within the carboxyl-terminus of the angiotensin II (AT1A) receptor.
FEBS Lett.
45
1999
367
371
24
Ward
CM
Andrews
RK
Smith
AI
Berndt
MC
Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα binding site for von Willebrand factor and α-thrombin.
Biochemistry.
35
1996
4929
4938
25
Fox
JEB
Berndt
MC
cAMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets.
J Biol Chem.
264
1989
9520
9526
26
O'Neil
KT
Wolfe
HR
Jr
Erickson-Viitanen
S
DeGrado
WF
Fluorescence properties of calmodulin-binding peptides reflect α-helical periodicity.
Science.
236
1987
1454
1456
27
Kahn
J
Walcheck
B
Migaki
GI
Jutila
MA
Kishimoto
TK
Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism.
Cell.
92
1998
809
818
28
O'Connor
V
El Far
O
Bofill-Cardona
E
et al
Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling.
Science.
286
1999
1180
1183
29
Fischer
R
Koller
M
Flura
M
et al
Multiple divergent mRNAs code for a single human calmodulin.
J Biol Chem.
263
1988
17055
17062
30
Alexander
KA
Wakim
BT
Doyle
GS
Walsh
KA
Storm
DR
Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein.
J Biol Chem.
263
1988
7544
7549
31
Gerendasy
DD
Herron
SR
Jennings
PA
Sutcliffe
JG
Calmodulin stabilizes an amphiphilic α-helix within RC3/neurogranin GAP-43/neuromodulin only when Ca2+ is absent.
J Biol Chem.
270
1995
6741
6750
32
Baudier
J
Deloulme
JC
Van Dorsselaer
A
Black
D
Matthes
HW
Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17): identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain.
J Biol Chem.
266
1991
229
237
33
James
P
Vorherr
T
Carafoli
E
Calmodulin-binding domains: just two faced or multi-faceted?
Trends Biochem Sci.
20
1995
38
42
34
Aderem
A
The MARCKS brothers: a family of protein kinase C substrates.
Cell.
71
1992
713
716
35
Wardell
MR
Reynolds
CC
Berndt
MC
Wallace
RW
Fox
JEB
Platelet glycoprotein Ib β is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase.
J Biol Chem.
264
1989
15656
15661
36
Andrews
RK
Fox
JEB
Identification of a region from the cytoplasmic domain of the platelet membrane GP Ib-IX complex that binds to purified actin-binding protein.
J Biol Chem.
267
1992
18605
18611
37
Cunningham
JG
Meyer
SC
Fox
JEB
The cytoplasmic domain of the α-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology.
J Biol Chem.
271
1996
11581
11587
38
Muszbek
L
Laposata
M
Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages.
J Biol Chem.
264
1989
9716
9719
39
He
Q
Dent
EW
Meiri
KF
Modulation of actin filament behavior by GAP-43 (neuromodulin) is dependent on the phosphorylation status of serine 41, the protein kinase C site.
J Neurosci.
17
1997
3515
3524
40
Chakravarthy
B
Morley
P
Whitfield
J
Ca2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains.
Trends Neurosci.
22
1999
12
16
41
Wohnsland
F
Schmitz
AAP
Steinmetz
MO
Aebi
U
Vergeres
G
Interaction between actin and the effector peptide of MARCKS-related protein: identification of functional amino acid segments.
J Biol Chem.
275
2000
20873
20879
42
Laux
T
Fukami
K
Thelen
M
Golub
T
Frey
D
Caroni
P
GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism.
J Cell Biol.
149
2000
1455
1471
43
Kobayashi
M
Nagata
S
Kita
Y
et al
Expression of a constitutively active phosphatidylinositol 3-kinase induces process formation in rat PC12 cells: use of Cre/loxP recombination system.
J Biol Chem.
272
1997
16089
16092

Author notes

Robert K. Andrews, Baker Medical Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria, Australia, 8008; e-mail: rkandrews@hotmail.com.

Sign in via your Institution